Mechanism and Research Interest

Primary Biological Pathway: The KPV “Inflammation Brake” The distinguishing feature of the Klow blend is the addition of KPV (Lysine-Proline-Valine). This C-terminal tripeptide of $\alpha$-MSH (Alpha-Melanocyte Stimulating Hormone) exhibits profound anti-inflammatory properties without the pigmentary effects of the full hormone. Research utilising this pen investigates KPV’s ability to enter the nucleus and inhibit NF-$\kappa$B activation, effectively dampening the “cytokine storm” that often arrests the healing process in chronic wounds. In this 80mg blend, KPV acts as the permissive gatekeeper, reducing the inflammatory noise so that the regenerative signals of GHK-Cu, BPC-157, and TB-500 can function optimally.

Secondary Research Finding: Synergistic Remodelling The “Glow” core remains intact but is supercharged.

1. GHK-Cu (50mg): Stimulates fibroblast production of Collagen I/III and Elastin.

2. TB-500 (10mg): Sequesters actin to promote rapid cell migration to the injury site.

3. BPC-157 (10mg): Drives angiogenesis via VEGF. The Klow 80mg pen is utilised in models of Complex Tissue Trauma (e.g., burns or crush injuries) to quantify the rate of closure and the tensile strength of the healed tissue, testing the hypothesis that controlling inflammation (via KPV) accelerates the transition from the inflammatory phase to the proliferative phase of healing.

Tertiary Research Finding: The Gut-Skin Axis Both BPC-157 and KPV have documented efficacy in mucosal healing. KPV is extensively studied in models of ulcerative colitis for its ability to reduce intestinal inflammation. This blend is unique for researching the Gut-Skin Axis. Investigators use the Klow pen to study systemic repair, positing that the simultaneous repair of the gut barrier (reducing systemic endotoxemia) and the skin barrier (improving dermal integrity) leads to superior overall phenotypic outcomes compared to treating either system in isolation.

Long-term Genomic and Safety Observations Safety pharmacology focuses on Copper Homeostasis. With 50mg of GHK-Cu, the copper load is significant. Longitudinal studies monitor serum ceruloplasmin and hepatic copper levels to ensure that the trace mineral remains bound within the peptide complex and does not accumulate as free copper, which can be pro-oxidative. The addition of KPV, which has antimicrobial properties (specifically against S. aureus and C. albicans), also allows for the observation of microbiome shifts during chronic administration.

Product Specifications

• Purity: Each of the four peptides is individually synthesised and validated via HPLC before blending. We utilize a specific “cold-mix” protocol to ensure that the copper ion from GHK-Cu does not prematurely chelate with the histidine residues in the other peptide chains during the lyophilisation process.

• Appearance: The 3ml pen contains a deep blue, sterile liquid.

• Precision: The pen delivery system allows for the administration of this four-part cocktail in a single micro-dosing step. This is essential for reducing experimental variability; trying to mix four separate variables manually introduces unacceptable pipetting error.

• Storage: The product must be stored at 2∘C to 8∘C.

Storage and Shipping Guidelines

Refrigeration and Shelf Life The Klow 80mg Pen is a complex chemical environment. Refrigeration (2∘C to 8∘C) is mandatory. The shelf life is 12 months in the sealed state. Once the pen is accessed, the bacteriostatic environment preserves the solution for 28 days. The presence of KPV enhances the antimicrobial stability of the solution, but thermal stress can still degrade the peptide bonds.

Shipping Stability We utilise medical-grade thermal packaging. The peptide is stable for up to 72 hours at ambient UK temperatures. However, to maintain the precise stoichiometry of this quad-blend, we strongly recommend selecting the fastest available shipping option.

Freezing Warning Strictly avoid freezing. Freezing is catastrophic for GHK-Cu (dissociation) and BPC-157 (aggregation). Furthermore, freeze-thaw cycles can cause phase separation of the different peptide densities. A frozen Klow pen will likely exhibit precipitation and should be considered compromised.

Why Choose the Peptide Pro 3ml Pen Format?

The Klow 80mg Pen is the definitive tool for Advanced Multi-Pathway Research. While the “Glow” blend covers regeneration, “Klow” covers Regeneration + Inflammatory Control.

If your research model involves sterile injury (e.g., surgical incision), “Glow” may suffice. However, if your model involves inflammatory pathology (e.g., autoimmune skin conditions, infected wounds, or inflammatory bowel disease), the Klow 80mg pen provides the necessary anti-inflammatory coverage via KPV to allow the regenerative agents to work. It is the “All-in-One” solution for difficult-to-heal phenotypes.

For researchers comparing blends, we recommend examining:

• Glow 70mg:  (The Triad blend without KPV).

• KPV 10mg: (To isolate the specific anti-inflammatory contribution).

• BPC-157 10mg: (For pure angiogenic/GI research).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection (e.g., for cosmetic skin treatments, acne therapy, or injury recovery), therapeutic use, or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.